πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6211207

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210670

Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin

Protein Design Labs, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210671

Humanized antibodies reactive with L-selectin

Protein Design Labs, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210680

Method for the prevention and treatment of chronic venous insufficiency

Univera Pharmaceuticals, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210707

Methods of forming protein-linked lipidic microparticles, and compositions thereof

The Regents of the University of California Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210708

Cationic virosomes as transfer system for genetic material

Nika Health Products Limited Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210873

Methods and compositions for the priming of specific cytotoxic T-lymphocyte response

The Board of Regents of the University of Texas System Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210887

Methods for evaluating colon tissue for expression of the DRA (down regulated in adenoma)

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210913

Modulation of integrin-mediated signal transduction

COR Therapeutics, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210917

Method for suppressing multiple drug resistance in cancer cells

The Regents of the University of California Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210918

Non-invasive method for detection, diagnosis or prediction of term or pre-term labor

The Regents of the University of California Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211148

Antimicrobial peptides from bovine neutrophis

The Regents of the University of California Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211149

Inhibitors of formation of protease resistant prion protein

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211154

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211165

Methods and compositions for reducing ischemic injury of the heart by administering adenos

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211168

Methods for preparation and use of 1.alpha.,24 (S)-dihydroxy vitamin D2

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211183

Selective factor Xa inhibitors

COR Therapeutics, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211195

CRF antagonistic thiophenopyridines

Neurocrine Biosciences, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211200

Metal complexes

Ligand Pharmaceuticals Incorporated Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211205

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211355

Radionuclide labeling of vitamin B12 and coenzymes thereof

Regents of the University of Minnesota Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211206

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211215

Heterocyclic compounds, their production and use

Takeda Chemical Industries Ltd. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6207170

Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes

Biomira USA Inc. Β· Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired